CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Novartis AG Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis with three other pharmaceutical manufacturers in Europe: Roche Holding Aktiengesellschaft (2018 sales of 56.85 billion Swiss Francs [US$57.19 billion] of which 77% was Pharmaceuticals), Sanofi S.A. of France (35.68 billion Euro [US$40.04 billion] of which 69% was Pharmaceuticals), and Bayer AG which is based in Germany (39.59 billion Euro [US$44.43 billion] of which 42% was Pharmaceuticals & Biological Products).

Sales Analysis. Novartis reported sales of 51.94 billion Swiss Francs (US$52.25 billion) for the year ending December of 2018. This represents an increase of 5.7% versus 2017, when the company's sales were 49.16 billion Swiss Francs. This was the third consecutive year of growth at Novartis. The sales level in 2018 was fairly close to the level five years ago: in 2013, Novartis had sales of 54.36 billion Swiss Francs. Sales of Alcon saw an increase that was more than double the company's growth rate: sales were up 18.2% in 2018, from 5.91 billion Swiss Francs to 6.98 billion Swiss Francs. Not all segments of Novartis experienced an increase in sales in 2018: sales of Sandoz fell 2.4% to 9.63 billion Swiss Francs.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Novartis AG
  Stock Performance Chart for Novartis AG
 
  Stock Data: Recent Stock Performance:
  Current Price (6/21/2019): 90.12
(Figures in Swiss Francs)
1 Week 0.8%   13 Weeks 3.3%  
4 Weeks -3.1%   52 Weeks 20.7%  
 
Novartis AG Key Data:
  Ticker: NOVN Country: Switzerland
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 51,938,397,060
(Year Ending Jan 2019).
Employees: 125,161
  Currency: Swiss Francs Market Cap: 209,333,254,494
  Fiscal Yr Ends: December Shares Outstanding: 2,322,827,946
  Share Type: Namenaktie Closely Held Shares: 90,915,965
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.